SCHEMBL23579986

SCHEMBL23579986

NC(=O)c1ccccc1N1C[C@@H]2COCC[C@@H]2Oc2nc3[nH]ccc3cc21

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALOX5AP P20292 2/20 0.34
▸ FEN1 P39748 2/20 0.34
▸ SCN9A Q15858 1/20 0.33
▸ PIK3CA P42336 1/20 0.31
▸ HCRTR1 O43613 1/20 0.31
▸ HCRTR2 O43614 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ OPRM1 P35372 1/20 0.31
▸ OPRL1 P41146 1/20 0.31
▸ JAK2 O60674 2/20 0.30
▸ JAK1 P23458 2/20 0.30
▸ BTK Q06187 1/20 0.30
▸ TYK2 P29597 1/20 0.30
▸ JAK3 P52333 1/20 0.30
▸ BRD4 O60885 1/20 0.30
▸ PDPK1 O15530 1/20 0.30
▸ CYP11B1 P15538 1/20 0.30
▸ CYP11B2 P19099 1/20 0.30
▸ NUDT1 P36639 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23579437 1.00 ALOX5AP (0.34) ALOX5APFEN1SCN9APIK3CAHCRTR1
SCHEMBL23578855 1.00 ALOX5AP (0.34) ALOX5APFEN1SCN9APIK3CAHCRTR1
SCHEMBL23579445 0.92 OPRM1 (0.33) ALOX5APFEN1SCN9AHCRTR1HCRTR2
SCHEMBL23165655 0.92 OPRM1 (0.33) ALOX5APFEN1SCN9AHCRTR1HCRTR2
SCHEMBL23579454 0.92 OPRM1 (0.33) ALOX5APFEN1SCN9AHCRTR1HCRTR2
SCHEMBL29747346 0.85 JAK2 (0.35) ALOX5APFEN1JAK2JAK1TYK2
SCHEMBL25284683 0.83 GRM5 (0.33) ALOX5APFEN1PIK3CAJAK2JAK1
SCHEMBL23579290 0.83 GRM5 (0.33) ALOX5APFEN1PIK3CAJAK2JAK1
SCHEMBL23579340 0.83 GRM5 (0.33) ALOX5APFEN1PIK3CAJAK2JAK1
SCHEMBL21751548 0.82 PRKCA (0.35) ALOX5APFEN1SCN9AOPRM1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021133817-A1 1H-PYRROLO[2,3-B]PYRIDINE DERIVATIVES AS BCL-2 INHIBITORS FOR THE TREATMENT OF NEOPLASTIC AND AUTOIMMUNE DISEASES Guangzhou Lupeng Pharmaceutical Company Ltd. (CN) 2021-07-01 — — WO disclosed
Send feedback